Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI

NCT06545747 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

490

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

RADIATION: DCE-MRI based split-course hypo-RT
RADIATION: CT based split-course hypo-RT
DRUG: Concurrent chemotherapy
DRUG: Consolidative immunotherapy

Sponsor

Sun Yat-sen University